Literature DB >> 23206889

Intermittent fasting: a "new" historical strategy for controlling seizures?

Adam L Hartman1, James E Rubenstein, Eric H Kossoff.   

Abstract

In antiquity, fasting was a treatment for epilepsy and a rationale for the ketogenic diet (KD). Preclinical data indicate the KD and intermittent fasting do not share identical anticonvulsant mechanisms. We implemented an intermittent fasting regimen in six children with an incomplete response to a KD. Three patients adhered to the combined intermittent fasting/KD regimen for 2 months and four had transient improvement in seizure control, albeit with some hunger-related adverse reactions.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh：

Year:  2012        PMID： 23206889      PMCID： PMC3740951          DOI： 10.1016/j.eplepsyres.2012.10.011

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN： 0920-1211            Impact factor:   3.045


  19 in total

Review 1.  The use of diet in the treatment of epilepsy.

Authors:  Elizabeth E Bailey; Heidi H Pfeifer; Elizabeth A Thiele
Journal:  Epilepsy Behav       Date:  2005-02       Impact factor: 2.937

2.  Food restriction reduces brain damage and improves behavioral outcome following excitotoxic and metabolic insults.

Authors:  A J Bruce-Keller; G Umberger; R McFall; M P Mattson
Journal:  Ann Neurol       Date:  1999-01       Impact factor: 10.422

3.  Brain-derived neurotrophic factor mediates an excitoprotective effect of dietary restriction in mice.

Authors:  W Duan; Z Guo; M P Mattson
Journal:  J Neurochem       Date:  2001-01       Impact factor: 5.372

4.  Neuroprotective potential of dietary restriction against kainate-induced excitotoxicity in adult male Wistar rats.

Authors:  Sandeep Sharma; Gurcharan Kaur
Journal:  Brain Res Bull       Date:  2005-08-30       Impact factor: 4.077

5.  Early identification of refractory epilepsy.

Authors:  P Kwan; M J Brodie
Journal:  N Engl J Med       Date:  2000-02-03       Impact factor: 91.245

6.  The ketogenic diet: a 3- to 6-year follow-up of 150 children enrolled prospectively.

Authors:  C Hemingway; J M Freeman; D J Pillas; P L Pyzik
Journal:  Pediatrics       Date:  2001-10       Impact factor: 7.124

Review 7.  Ketogenic diets: new advances for metabolism-based therapies.

Authors:  Eric H Kossoff; Adam L Hartman
Journal:  Curr Opin Neurol       Date:  2012-04       Impact factor: 5.710

8.  Application of a ketogenic diet in children with autistic behavior: pilot study.

Authors:  Athanasios Evangeliou; Ioannis Vlachonikolis; Helen Mihailidou; Martha Spilioti; Astrinia Skarpalezou; Nikolaos Makaronas; Ahilleas Prokopiou; Panagiotis Christodoulou; Georgia Liapi-Adamidou; Emmanouel Helidonis; Stylianos Sbyrakis; Jan Smeitink
Journal:  J Child Neurol       Date:  2003-02       Impact factor: 1.987

9.  Calorie restriction and ketogenic diet diminish neuronal excitability in rat dentate gyrus in vivo.

Authors:  Kristopher J Bough; Philip A Schwartzkroin; Jong M Rho
Journal:  Epilepsia       Date:  2003-06       Impact factor: 5.864

10.  Dietary restriction differentially protects from neurodegeneration in animal models of excitotoxicity.

Authors:  Andrea Contestabile; Elisabetta Ciani; Antonio Contestabile
Journal:  Brain Res       Date:  2004-03-26       Impact factor: 3.252
View more
  26 in total

1.  Calorie or carbohydrate restriction? The ketogenic diet as another option for supportive cancer treatment.

Authors:  Rainer J Klement
Journal:  Oncologist       Date:  2013

2.  Dietary and medication adjustments to improve seizure control in patients treated with the ketogenic diet.

Authors:  Jessica H Selter; Zahava Turner; Sarah C Doerrer; Eric H Kossoff
Journal:  J Child Neurol       Date:  2014-05-22       Impact factor: 1.987

Review 3.  The changing face of dietary therapy for epilepsy.

Authors:  Ludovica Pasca; Valentina De Giorgis; Joyce Ann Macasaet; Claudia Trentani; Anna Tagliabue; Pierangelo Veggiotti
Journal:  Eur J Pediatr       Date:  2016-09-01       Impact factor: 3.183

Review 4.  Fasting: molecular mechanisms and clinical applications.

Authors:  Valter D Longo; Mark P Mattson
Journal:  Cell Metab       Date:  2014-01-16       Impact factor: 27.287

Review 5.  Intermittent metabolic switching, neuroplasticity and brain health.

Authors:  Mark P Mattson; Keelin Moehl; Nathaniel Ghena; Maggie Schmaedick; Aiwu Cheng
Journal:  Nat Rev Neurosci       Date:  2018-01-11       Impact factor: 34.870

6.  Fasting-mimicking diet and markers/risk factors for aging, diabetes, cancer, and cardiovascular disease.

Authors:  Min Wei; Sebastian Brandhorst; Mahshid Shelehchi; Hamed Mirzaei; Chia Wei Cheng; Julia Budniak; Susan Groshen; Wendy J Mack; Esra Guen; Stefano Di Biase; Pinchas Cohen; Todd E Morgan; Tanya Dorff; Kurt Hong; Andreas Michalsen; Alessandro Laviano; Valter D Longo
Journal:  Sci Transl Med       Date:  2017-02-15       Impact factor: 17.956

Review 7.  The neuropathology of obesity: insights from human disease.

Authors:  Edward B Lee; Mark P Mattson
Journal:  Acta Neuropathol       Date:  2013-10-06       Impact factor: 17.088

8.  Glycemic modulation in neuro-oncology: experience and future directions using a modified Atkins diet for high-grade brain tumors.

Authors:  Roy E Strowd; Mackenzie C Cervenka; Bobbie J Henry; Eric H Kossoff; Adam L Hartman; Jaishri O Blakeley
Journal:  Neurooncol Pract       Date:  2015-05-26

9.  Reduced glucose utilization underlies seizure protection with dietary therapy in epileptic EL mice.

Authors:  Joshua J Meidenbauer; Mary F Roberts
Journal:  Epilepsy Behav       Date:  2014-09-07       Impact factor: 2.937

10.  M-Channel Activation Contributes to the Anticonvulsant Action of the Ketone Body β-Hydroxybutyrate.

Authors:  Rían W Manville; Maria Papanikolaou; Geoffrey W Abbott
Journal:  J Pharmacol Exp Ther       Date:  2019-11-22       Impact factor: 4.030
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.